EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exome Sequencing Identifies Variants in MLH1 and ERBB2 as Potential Cancer‐Predisposing Factors in Familial Early‐Onset Colorectal Cancer

Behnaz Bagheri, Neda Mohsen-Pour, Najmeh Salehi, Pardis Ketabi Moghadam iD, Adel Zeinalpour, Amir Sadeghi, Samira Kalayinia iD, Nayeralsadat Fatemi iD

The Kaohsiung Journal of Medical Sciences · 2026

DOI: 10.1002/kjm2.70166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2026. Verfasst von Behnaz Bagheri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Be…. Hauptthemen laut MEDLINE: MutL Protein Homolog 1, Genetic Predisposition to Disease, Colorectal Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) has raised considerable health concerns worldwide, with increasing incidence rates, specifically among younger populations. Despite remarkable progress in diagnosing and treating various diseases, the genetic basis of CRC remains only partially understood. This paper aims to examine novel genetic variants associated with CRC in Iranian patients. We performed whole‐exome sequencing (WES) in two Iranian families with a history of early‐onset CRC. Candidate variants were validated by Sanger sequencing and assessed for segregation. Pathogenicity was evaluated through comprehensive in silico analysis and the application of ACMG/AMP guidelines. Analysis revealed two clinically significant variants. In Family 1, we identified a heterozygous stop‐gain variant in MLH1 (c.1043T>A, p.Leu348), a known pathogenic mutation consistent with Lynch syndrome. In Family 2, we discovered a previously undocumented heterozygous missense variant in ERBB2 (c.2268G>T, p.Arg756Ser). Through a detailed ACMG assessment, this ERBB2 variant was classified as Likely Pathogenic based on its location in a critical tyrosine kinase domain, absence from population databases, and concordant deleterious in silico predictions. WES offers a deeper understanding of CRC genetics, suggesting potential biomarkers with promising applications for early diagnosis and targeted treatments, eventually improving patient‐related outcomes. The results of this study underscore the significant contribution of genetic screening to the well‐being of high‐risk families and offer valuable insights for targeted therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutL Protein Homolog 1Genetic Predisposition to DiseaseColorectal NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansExome SequencingFemalePedigreeMaleAge of OnsetAdultMiddle AgedColorectal Neoplasms, Hereditary NonpolyposisExomeHeterozygote

Stichwörter der Autor:innen

ERBB2MLH1colorectal cancerearly‐onsetwhole exome sequencing

Substanzen

MutL Protein Homolog 1MLH1 protein, humanErb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
  • School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of General Surgery, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.

ORCID-Profile: Pardis Ketabi Moghadam, Samira Kalayinia, Nayeralsadat Fatemi

Zitieren

APA

Bagheri, B., Mohsen-Pour, N., Salehi, N., Moghadam, P. K., Zeinalpour, A., Sadeghi, A., Kalayinia, S., & Fatemi, N. (2026). Exome Sequencing Identifies Variants in MLH1 and ERBB2 as Potential Cancer‐Predisposing Factors in Familial Early‐Onset Colorectal Cancer. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70166

Vancouver

Bagheri B, Mohsen-Pour N, Salehi N, Moghadam PK, Zeinalpour A, Sadeghi A, et al. Exome Sequencing Identifies Variants in MLH1 and ERBB2 as Potential Cancer‐Predisposing Factors in Familial Early‐Onset Colorectal Cancer. The Kaohsiung Journal of Medical Sciences. 2026. doi:10.1002/kjm2.70166

BibTeX
@article{Bagheri2026,
  author = {Bagheri, Behnaz and Mohsen-Pour, Neda and Salehi, Najmeh and Moghadam, Pardis Ketabi and Zeinalpour, Adel and Sadeghi, Amir and Kalayinia, Samira and Fatemi, Nayeralsadat},
  title = {Exome Sequencing Identifies Variants in MLH1 and ERBB2 as Potential Cancer‐Predisposing Factors in Familial Early‐Onset Colorectal Cancer},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2026},
  doi = {10.1002/kjm2.70166}
}
Kostenlos starten →